Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Ghebrehewet S, MacPherson P, Ho A. Influenza. BMJ. 2016.
https://doi.org/10.1136/bmj.i6258
.
2. European Centre for Disease Prevention and Control. Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza. 2017.
http://www.ecdc.europa.eu
. Accessed 2 Aug 2018.
3. Hurt AC. The epidemiology and spread of drug resistant human influenza viruses. Curr Opin Virol. 2014;8:22–9.
4. McLaughlin MM, Skoglund EW, Ison MG. Peramivir: an intravenous neuraminidase inhibitor. Expert Opin Pharmacother. 2015;16(12):1889–900.
5. Babu YS, Chand P, Bantia S, et al. BCX-1812 (RWJ-270201): a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem. 2000;43(19):3482–6.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献